Radiomics has been used in the diagnosis, subtype differentiation, prediction of anticancer therapies and prognosis of lung adenocarcinomas,17, 18, 19, 20 however, it has been rarely used in the evaluation of Ki‐67 LI of lung adenocarcinoma. This evidence concerns the gene MKI67 and lung adenocarcinoma.